Adrienne H Brouwers

19PUBLICATIONS
85CO-AUTHORS
Molecular targetsMedical physicsPredictive and prognostic markersFoetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 10, 2026
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|May 04, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

|Mar 17, 2026
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technology.

Ilja S Deurloo, Milou M Steemers-de Boer, Johannes H van Snick

|Nov 25, 2025
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Sep 26, 2024
Molecular imaging supports the development of multispecific cancer antibodies.

Claudia A J van Winkel, Frank R Pierik, Adrienne H Brouwers

Pageof 4

Frequent Collaborators

8 joint publications

Elisabeth Ge de Vries

6 joint publications

Marjolijn N Lub-de Hooge

4 joint publications

Derk-Jan A de Groot

4 joint publications

Sjoerd G Elias